Endoscopic Characterization of Colorectal Neoplasia With the Different Published Classifications
NCT ID: NCT04048447
Last Updated: 2019-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
206 participants
OBSERVATIONAL
2018-08-01
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endoscopic Characterization of Colorectal Neoplasia With the Different Published Classifications: a Prospective Comparative Study
NCT04223947
Histological Prediction and Choice of the Resection Strategy in Front of a Colorectal Lesion > 2 cm: Prospective Comparison of Endoscopic Characterization, Non-targeted and Targeted Biopsies
NCT04482491
A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia
NCT01816438
Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal Tumors
NCT03470883
Discard:Characterisation of Colonic Polyps in Vivo
NCT00888771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lesions presented were resected endoscopically after completion of a picture file.
* Pathology available for presented lesions.
* Participants signed informed consent and voluntarily participated in the characterization of these 206 lesions.
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital Edouard Herriot
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean Christophe Saurin
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edouard Herriot Hospital
Lyon, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFED PROTOCOL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.